» Articles » PMID: 35064195

Noise Exposure Levels Predict Blood Levels of the Inner Ear Protein Prestin

Overview
Journal Sci Rep
Specialty Science
Date 2022 Jan 22
PMID 35064195
Authors
Affiliations
Soon will be listed here.
Abstract

Serological biomarkers of inner ear proteins are a promising new approach for studying human hearing. Here, we focus on the serological measurement of prestin, a protein integral to a human's highly sensitive hearing, expressed in cochlear outer hair cells (OHCs). Building from recent nonhuman studies that associated noise-induced OHC trauma with reduced serum prestin levels, and studies suggesting subclinical hearing damage in humans regularly engaging in noisy activities, we investigated the relation between serum prestin levels and environmental noise levels in young adults with normal clinical audiograms. We measured prestin protein levels from circulating blood and collected noise level data multiple times over the course of the experiment using body-worn sound recorders. Results indicate that serum prestin levels have a negative relation with noise exposure: individuals with higher routine noise exposure levels tended to have lower prestin levels. Moreover, when grouping participants based on their risk for a clinically-significant noise-induced hearing loss, we found that prestin levels differed significantly between groups, even though behavioral hearing thresholds were similar. We discuss possible interpretations for our findings including whether lower serum levels may reflect subclinical levels of OHC damage, or possibly an adaptive, protective mechanism in which prestin expression is downregulated in response to loud environments.

Citing Articles

Examining sound levels across different time scales measured from body-worn dosimetersa).

Jorgensen E, Tufts J, Skoe E J Acoust Soc Am. 2025; 157(2):1483-1499.

PMID: 40014481 PMC: 11878219. DOI: 10.1121/10.0035807.


Changes in Plasma Levels of Prestin and Otolin-1 in Dental Students.

Lee J, Miser S, OConnor K, Bedinghaus C, Tomeo G, Badawy M Cureus. 2025; 16(12):e75719.

PMID: 39811239 PMC: 11730730. DOI: 10.7759/cureus.75719.


Verification of Outer Hair Cell Motor Protein, Prestin, as a Serological Biomarker for Mouse Cochlear Damage.

Zheng J, Zhou Y, Fuentes R, Tan X Int J Mol Sci. 2024; 25(13).

PMID: 39000390 PMC: 11241755. DOI: 10.3390/ijms25137285.


Prestin in Human Perilymph, Cerebrospinal Fluid, and Blood as a Biomarker for Hearing Loss.

Gadenstaetter A, Krumpoeck P, Auinger A, Yildiz E, Tu A, Matula C Otolaryngol Head Neck Surg. 2024; 171(6):1825-1833.

PMID: 38988299 PMC: 11605028. DOI: 10.1002/ohn.895.


Serum Prestin and Otolin-1 Levels in Pilots of Helicopter-Based Emergency Medical Services: Potential Markers for Ear Injury.

Minoretti P, Santiago Saez A, Liano Riera M, Gomez Serrano M, Garcia Martin A Cureus. 2024; 16(3):e55936.

PMID: 38601380 PMC: 11005077. DOI: 10.7759/cureus.55936.


References
1.
Olusanya B, Davis A, Hoffman H . Hearing loss: rising prevalence and impact. Bull World Health Organ. 2019; 97(10):646-646A. PMC: 6796666. DOI: 10.2471/BLT.19.224683. View

2.
Wallhagen M, Pettengill E . Hearing impairment: significant but underassessed in primary care settings. J Gerontol Nurs. 2008; 34(2):36-42. DOI: 10.3928/00989134-20080201-12. View

3.
Zazove P, Plegue M, McKee M, DeJonckheere M, Kileny P, Schleicher L . Effective Hearing Loss Screening in Primary Care: The Early Auditory Referral-Primary Care Study. Ann Fam Med. 2020; 18(6):520-527. PMC: 7708285. DOI: 10.1370/afm.2590. View

4.
He D, Lovas S, Ai Y, Li Y, Beisel K . Prestin at year 14: progress and prospect. Hear Res. 2013; 311:25-35. PMC: 4061261. DOI: 10.1016/j.heares.2013.12.002. View

5.
Oghalai J . The cochlear amplifier: augmentation of the traveling wave within the inner ear. Curr Opin Otolaryngol Head Neck Surg. 2004; 12(5):431-8. PMC: 1315292. DOI: 10.1097/01.moo.0000134449.05454.82. View